Avanafil
- Strength
- 100 mg/1
- Form
- Tablet
- Class
- Phosphodiesterase 5 Inhibitor
Camber Pharmaceuticals, Inc.
Listed by Camber Pharmaceuticals, Inc.
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Phosphodiesterase 5 Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 31722-442 |
| FDA application | ANDA209266 |
| RxNorm concept | 1291306 |
| Package sizes listed | 2 |
| Marketed since | June 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.